Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Mar 26, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Frank Pitzer has been named CEO of Roche NimbleGen. Pitzer has been with Roche for more than eight years, most recently as head of divisional quality and regulatory affairs at Roche Diagnostics.

"Frank's leadership skills and extensive experience in the life science industry make him the perfect fit to guide Roche NimbleGen through the next stages of growth," Manfred Baier, head of Roche Applied Science, said in a statement. "His valuable insight and outstanding management experience will further entrench the company as a leading manufacturer of microarray technologies."


Bio-Rad Laboratories has appointed Ted Love to serve on its board of directors and on the board's audit committee. The move enabled the company to regain compliance with regulations of the New York Stock Exchange, which requires that a listed company have three independent directors on its audit committee. Love currently is executive VP of R&D at Onyx Pharmaceuticals, and from 2001 to 2009 he was president and CEO of Nuvelo. Love also previously spent six years in senior management at Genentech.


NanoString has tapped William Young to be executive chairman of its board of directors. Young formerly was CEO and chairman of Monogram Biosciences and he was COO at Genentech. He currently serves as chairman of the board of directors of Biogen, is chairman emeritus for BayBio, and he is a director at Theravance.


Complete Genomics has named Mark Sutherland senior VP of business development. He formerly was VP of genomics at Amersham Biosciences, where he focused on running the DNA sequencing, genotyping, and gene expression business. Sutherland recently was VP of business development at GenVault, and before that he was VP of strategic alliances for GE Healthcare's Discovery Systems Business.


Gen-Probe has named Brian McNamee, who is CEO of the drug company CSL, to re-join the company's board of directors. McNamee already served on the company's board of directors from 2002 to 2007. He has been CEO and managing director of CSL since 1990.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.